WHO ICTRP trial
The use of indocyanine green for accurate sentinel node detection and removal in…
NL-OMON44119 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON44119 |
|---|---|
| Public title | The use of indocyanine green for accurate sentinel node detection and removal in a group of high-risk nodal metastasis prostate cancer patients To optimize and improve the sentinel node procedure in men with prostate cancer |
| Scientific title | The use of indocyanine green for accurate sentinel node detection and removal in a group of high-risk nodal metastasis prostate cancer patients To optimize and improve the sentinel node procedure in men with prostate cancer - Optical sentinel node detection in prostate cancer |
| Primary sponsor | Antoni van Leeuwenhoek Ziekenhuis |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | The Netherlands |
| Conditions | prostate cancer prostate carcinoma;10038597;10036958;prostate cancer;prostate carcinoma |
| Interventions | No special patient preparation is required. Approximately 4 hours prior to surgery ICG-99mTc-nanocolloid will be injected transrectally under ultrasound guidance into the prostate tumor as is routinely done for 99mTc-nanocolloid guided… |
| Registration date | Jan 29, 2016 |
| Target size | 112 |
| Secondary IDs | NL41285.031.12 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: